IWY iShares Russell Top 200 Growth ETF

Expense Ratio
0.2%
Dividend
0.33%
Previous close
$291.73
Est. 12 months change
-21.53%
Projected Price
$228.91

Profitability Metrics

Return on Equity (ROE)
68.49%
Return on Assets (ROA)
20.48%
Return on Invested Capital (ROIC)
57.59%
Weighted Average Cost of Capital (WACC)
11.42%
ROIC - WACC
46.18%
Updated : 2026-05-18 20:19 ET

Valuation Metrics

P/E Ratio
36.07
Forward P/E
28.01
PEG Ratio
1.82
Debt Current Ratio
1.99

Growth & Cash Flow

Gross Margin
61.07%
Operating Margin
36.41%
FCF Margin
28.73%
TTM Revenue Growth
29.91%
Projected 12M EPS Growth
28.80%

Price Change

Price % from 50 SMA
8.67%
Price % from 200 SMA
7.97%
6 Months
8.11%
1 Year
25.20%
2 Years
46.12%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA16.67%
AAPL13.01%
MSFT9.24%
AVGO5.17%
AMZN4.82%
GOOGL4.63%
GOOG3.73%
TSLA3.55%
META3.12%
LLY2.66%

ETF Analysis

Fund Overview

iShares Russell Top 200 Growth ETF (IWY) currently reports 109 stock positions (subject to change), placing it in the widely spread range by holdings breadth. The top line-up is NVDA (16.67%), AAPL (13.01%), MSFT (9.24%), with NVDA as the largest single weight at 16.67%. Together, the top three holdings account for 38.92%, which implies that short-term performance can be meaningfully influenced by a narrow set of large constituents. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 57.59%, WACC is 11.42%, and the economic spread is 46.18%. On balance, the underlying businesses generate returns on capital that dramatically exceed their funding costs — a rare and powerful compounding dynamic. Supporting metrics show ROE at 68.49% and ROA at 20.48%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 36.07, forward P/E of 28.01, PEG of 1.82. The trailing-to-forward compression is moderate — supportive of valuation, but not a dramatic signal of earnings acceleration. The PEG ratio signals a portfolio priced at reasonable growth-adjusted value — adequate for the earnings outlook, without offering an obvious margin of safety. The current ratio of 1.99 is in an acceptable range, reflecting reasonable short-term financial health. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 61.07%, operating margin at 36.41%, and free cash flow margin at 28.73%. The gross margin here is a standout, pointing to businesses with durable unit economics and limited commodity exposure. Exceptional operating margins signal that overhead costs are well managed relative to the revenue base. Outstanding free cash flow margins signal businesses that convert revenues into cash at rates that support both reinvestment and shareholder returns. All three margin layers are constructive, pointing to a portfolio where quality of earnings is high and cash generation is reliable.

Growth & Forward Outlook

Projected 12-month EPS growth of 28.8% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 29.91% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of -21.75%, where the target profile indicates a negative expected price trajectory. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Taken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.